Effect of Fluid Overload in Different Periods on Outcome Among Acute Kidney Injury Patients Receiving Renal Replacement Therapy After Cardiac Surgery  by Zhouping, Zou et al.
Acute Kidney Injury S93Conclusion: These results suggest that RORalpha protects kidney from I/R
damage through transcriptional activation of HIF-1 and represents a poten-
tial therapeutic target for AKI.http://dx.doi.org/10.1016/j.hkjn.2015.09.0530028
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Objective: Cell therapy in renal ischemia-reperfusion injury (IRI) is currently
limited by low rates of cell engraftment after systemic delivery. In this
study, we investigated whether timing of mesenchymal stem cells (MSCs)
transplantation can determine the survival and therapeutic potential of
MSCs in ischemic kidney.
Methods: The model of renal I/R injury was induced by the release of bilat-
eral renal pedicle clamps following 60 min of occlusion. Six rats per group
were sacrificed per time point, at 0 h, 1 h, 12 h, 24 h, 48 h, 72 h and 1
week post-I/R respectively. MSCs were cultured with different time points
kidney homogenate supernatants. The animals were sacrificed 48 h after
reperfusion and 24 h after MSCs transplantation.
Results: The serum creatinine level peaked at 24 h of reflow and NGAL
peaked at 12 h. The highest expression of inflammatory factor was in 12 h
and 24 h groups, and the lower was in -1 h, 0 h and 1 w groups. In vitro, there
was lower cell apoptosis and higher proliferation in -1 h and 0 h groups
compared with other groups. Significant kidney function and histological
damage improvement was observed after the treatment of MSCs in -1 h
and 0 h groups. Meanwhile, the expression of proinflammatory factor signif-
icantly decreased and anti-inflammatory factor significantly decreased in
-1 h and 0 h groups compared with other point time groups and controlgroup. In addition, we also observed more obvious inhibition of renal tubular
cell apoptosis and promotion of proliferation in -1 h and 0 h groups compared
with other groups. Consistent with the improvement above, the viability of
implanted MSCs also increased in -1 h and 0 h groups.
Conclusion: MSCs transplanted 1 h before reperfusion or immediately
after reperfusion produce the most dramatic improvement in renal func-
tion and morphology in rat model of renal I/R injury. It is the optimal
timing to transplant MSCs in IRI before the inflammatory response is
established.http://dx.doi.org/10.1016/j.hkjn.2015.09.0540029
Changes in Epidemiology and Influencing Factors of Acute Kidney Injury
After Cardiac Surgery: A 5-year Study from 2009 to 2013
Zou Zhouping1,2, Xu Jiarui1,2, Fang Yi1,2, Zou Jianzhou1,2, Teng Jie1,2,
Ding Xiaoqiang1,2
1Division of Nephrology, Fudan University Zhongshan Hospital, Shanghai,
China
2Shanghai Institute for Kidney and Dialysis, Shanghai, China
Objective: We collected the epidemiological data of patients with AKI from
2009 to 2013 in order to explore the influencing factors of changes of epide-
miology after cardiac sugery.
Methods: Clinical data, which included demographic data of preoperative,
intraoperative, postoperative, were prospectively collected in our hospital
from January 2009 to December 2013. The main endpoint was poor prognosis
including overall mortality and abandon of treatment. The second point was
renal outcome.
Results: A total of 11693 patients enrolled, including 6637 males and 5056
females. The overall AKI incidence was 34.5%. The AKI incidence increased
during the five years from 34.2% to 36.5% (P < 0.05). There was no signifi-
cantly statistical differences in AKI-RRT incidences during the 5 years (P Z
0.360). The hospital mortality of AKI decreased from 6.3% in 2009 to 3.8%
in 2013. The incidence of poor prognosis in AKI were 8.3%, 7.5%, 6.8%,
5.1%, 8.0% (P Z 0.196). The mortality of AKI-RRT decreased from 47.1% in
2009 to 29.5% in 2013 (P Z 0.230). The incidence of poor prognosis in RRT
decreased from 66.7% to 57.4% (P Z 0.825). Multivariate logistic regression
analysis showed that male, old age, body mass index (every additional 5 kg/
m2), hypertension, chronic heart failure, pre-operative serum creatinine >
115 mmol/L, CPB (every additional 30 minutes) were the risk factors of AKI
after cardiac surgery.
Conclusion: The incidence of AKI after cardiac surgery increased from 2009
to 2013 and the rate of poor prognosis did not change.http://dx.doi.org/10.1016/j.hkjn.2015.09.0550030
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Objective: We explored the effect of fluid overload in different periods on
the outcome among acute kidney injury (AKI) patients receiving renal
replacement therapy (RRT) after cardiac surgery to guide the fluid manage-
ment strategy.
Methods: Clinical data of patients who developed AKI and received RRT after
cardiac surgery from January 2009 to April 2014 in our hospital were pro-
spectively analyzed. The absolute fluid overload (FO) Z fluid in (L) e fluid
out (L). Percent fluid overload (%FO) Z [(fluid in e fluid out)/admission
weight  100]. %FO  10% baseline weight was defined as fluid overload.
AKI was diagnosed according to the KDIGO guideline standard.
S94 Acute Kidney InjuryResults: A total of 297 patients were enrolled. The hospital mortality was
64.7%. The %FO at RRT initiation and at the end of RRT in the death group
was significantly higher than in survival group [5.0 (2.4, 9.3) vs. 2.5 (0.2,
5.8)%; 8.4 (3.6, 14.2) vs. 3.9 (0.4, 9.2)%; P < 0.05]. Among AKI-RRT patients,
the incidence of low cardiac output syndrome (LCOS) in the death group was
significantly higher than in the survival group (66.0% vs. 20.0%, P < 0.01). Hos-
pital mortality in the LCOS group was significantly higher than in the non-LCOS
group (81.9% vs. 56.7%, P < 0.001). The %FO at RRT initiation and at the end
of RRT in the LCOS group were higher than in the non-LCOS group (P < 0.05).
Conclusion: Among AKI-RRT patients after cardiac surgery, absolute FO and
%FO in the death group were higher than in the survivor group. Fluid over-
load and LCOS increased the risk of mortality.http://dx.doi.org/10.1016/j.hkjn.2015.09.0560038
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Objective: Recent studies indicate that Smad7 plays a protective role in
many chronic kidney diseases by attenuating both renal fibrosis and inflam-
mation. However, role of Smad7 in acute kidney injury (AKI) remains un-
clear, which was investigated in this study in a mouse model of AKI
induced in Smad 7 knockout (KO) mice.
Methods: Ischemia/reperfusion mouse model of AKI was induced in Smad7
KO mice and their WT (wild type) littermates by bilaterally clamping their
renal arteries with vascular clip for 45 min. In addition, a rescued study
was also performed in Smad7 KO mice by Smad7 gene transfer locally into
the kidney using a non-invasion ultrasound-microbubble technique. Effect
of disrupted or overexpressed renal Smad7 on renal function and tubular
epithelial cell regeneration was investigated.
Results: Compared to WT mice, Smad7 KO mice developed more severe
renal damage as demonstrated by a significant increase in serum creati-
nine and tubular necrosis at 48 hour. Future study revealed that cell pro-
liferation, detected by BrdU incorporation and PCNA expression, was
greatly suppressed in Smad7 KO mice after AKI. This was associated with
enhanced activation of Smad3 and up-regulation of CDK inhibitor p21
and p27, resulting in inactivation of cell cycling by suppressing CDK2 and
Cyclin E. In contrast, restored Smad7 locally in the kidney of Smad7 KO
mice attenuated the progression of AKI by reversing Smad3-dependent
p21/p27-induced inhibition of CKD2/Cyclin E-mediated tubular cell
proliferation.
Conclusion: Smad7 plays a protective role in the recovery process of AKI via
mechanism of inactivating TGF-b/Smad3-p21/p27-dependent inhibition of
CKD2/Cyclin pathway. Thus, Smad7 may be a novel therapeutic agent for
AKI.http://dx.doi.org/10.1016/j.hkjn.2015.09.057
0042
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Acute kidney injury is defined by an acute reduction in kidney function as
identified by an increase in the serum creatinine and reduction in urine
output. Kidney injury molecule-1 (Kim-1) is the hallmark of kidney
diseases which is normally not detectable in non-injured kidney but up-regulated and shed into the urine during the AKI. Aldosterone (Aldo) is an
important mediator of the renin-angiotensin-ALD system (RAAS) and plays
a pivotal role in the regulation of salt and extracelluar fluid metabolism. It
was found that RAAS induced the Kim-1 expression of proximal tubule
epithelial cells and the kidney injury while when treated with Aldo
receptor antagonist, the Kim-1 expression decreased and kidney injury
was eased. These results suggested that Aldo is related with the
expression of Kim-1 during AKI. Until now there is few molecular
mechanism reported about the mediation of Aldo to the Kim-1 expression.
In this research, we found that Aldo induced NRK cells apoptosis in AKI via
rno-miR-203 hypermethylation and Kim-1 upregulation, Kim-1 is a target
gene of rno-miR-203 in NRK cells. When cells were co-treated with pre-
miR-203 and spironolactone, cell apoptosis induced by Aldo reduced
significantly when compared with only treated with spironolactone. These
results may provide likely promising diagnostic marker or new therapeutic
target of acute kidney injury.http://dx.doi.org/10.1016/j.hkjn.2015.09.0580070
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Objective: Inflammation is a key feature of acute kidney injury (AKI). Macro-
phage migration inhibitory factor (MIF) is known as an upstream regulator of
immune and inflammatory responses. However, its role in AKI remains un-
clear, which was examined in this study.
Methods: An ischemia/reperfusion mouse model of AKI was induced in MIF
knockout (KO) and wild-type (WT) mice and groups of 8 mice were sacrificed
at day1, day2 and day7. Sham-operated mice were used as control. Serum
creatinine (Scr), tubular epithelial cell necrosis, MIF and NF-kB signaling,
and renal inflammation including F4/80+ macrophage infiltration and MCP-
1 and TNF-a expression were examined.
Results: Compared to sham-operated mice, MIF WT model mice developed
severe AKI including a significant increase in serum creatinine and tubular
necrosis, which was associated with upregulation of MIF signaling such as
upregulation of MIF and its receptor CD74 and activation of NF-kB
signaling, resulting in many macrophage infiltration and marked upregula-
tion of MCP-1 and TNF-a. In contrast, MIF KO mice were protected against
the development of AKI by lowering serum creatinine with less extent of
tubular necrosis. These protective effects were associated with suppres-
sion of NF-kB-dependent renal inflammation including fewer macrophages
and inhibition of MCP-1 and TNF-a expression in the AKI kidney (all
p < 0.01).
Conclusion: MIF plays a pathogenic role in AKI. Enhanced CD74-NF-kB-driven
renal inflammation may be a key mechanism by which MIF mediates AKI.http://dx.doi.org/10.1016/j.hkjn.2015.09.0590137
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Objective: AKI is a common critical condition, the incidence of which in-
creases with age. SIRT1, a NAD+-dependent deacetylase, has been shown
to have beneficial effects on both life span and renal health. NMN is a
NAD+ precursor involved in NAD+ recycle and thereby SIRT1 activity. This
study explores the role of SIRT1 and NMN in age-associated AKI, and mech-
anism by which SIRT1 deficiency aggravates AKI.
